2024). The study used propensity score matching to account for the possible effect of differences in age, ethnicity, socioeconomic determinants, and pre‐existing conditions, highlighting the significance of the impact of this intervention in outcomes. Preclinical studies have suggested that the proposed mechanism of action for this drug's effects on AD outcomes includes a reduction in Aβ plaques and tau tangles, enhanced autophagy, and increased glucose uptake (Wang et al. 2024). This evidence concerns the gene MAPT and Alzheimer disease.